Literature DB >> 12619164

t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia.

José L Vizmanos1, María J Larráyoz, Idoya Lahortiga, Filomena Floristán, Carmen Alvarez, María D Odero, Francisco J Novo, María J Calasanz.   

Abstract

Recently, it was shown that t(10;16)(q22;p13) fuses the MORF and CREBBP genes in a case of childhood acute myeloid leukemia (AML) M5a, with a complex karyotype containing other rearrangements. Here, we report a new case with the MORF-CREBBP fusion in an 84-year-old patient diagnosed with AML M5b, in which the t(10;16)(q22;p13) was the only cytogenetic aberration. This supports that this is a recurrent pathogenic translocation in AML. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12619164     DOI: 10.1002/gcc.10174

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

Review 1.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 3.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

4.  Therapy related acute myeloid leukemia with t(10:16): a rare entity.

Authors:  Guldeep K Uppal; John Leighton; Deline Da Costa; Andrew Czulewicz; Irma E Palazzo
Journal:  Hematol Rep       Date:  2011-12-15

5.  Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients.

Authors:  Angela Bentivegna; Donatella Milani; Cristina Gervasini; Paola Castronovo; Federica Mottadelli; Stefano Manzini; Patrizia Colapietro; Lucio Giordano; Francesca Atzeri; Maria T Divizia; Maria L Giovannucci Uzielli; Giovanni Neri; Maria F Bedeschi; Francesca Faravelli; Angelo Selicorni; Lidia Larizza
Journal:  BMC Med Genet       Date:  2006-10-19       Impact factor: 2.103

6.  Investigation of MYST4 histone acetyltransferase and its involvement in mammalian gametogenesis.

Authors:  Serge McGraw; Guillaume Morin; Christian Vigneault; Pierre Leclerc; Marc-André Sirard
Journal:  BMC Dev Biol       Date:  2007-11-02       Impact factor: 1.978

7.  MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.

Authors:  Hong Yin; Jonathan Glass; Kerry L Blanchard
Journal:  Mol Cancer       Date:  2007-08-13       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.